Related Experiment Video

Updated: Jun 28, 2025

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K

Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment

Fauzia Ullah1, Mariam Markouli2, Mark Orland1

  • 1Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44915, USA.

Cancers
|April 13, 2024
PubMed

Insights

Large granular lymphocytic (LGL) leukemia involves T-cell expansion and JAK-STAT pathway activation. New targeted therapies are needed due to current treatments

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocytic (LGL) leukemia is a chronic lymphoproliferative disorder.
  • It is characterized by clonal expansion of T or natural killer cells.
  • Associated with STAT3/STAT5 mutations and JAK-STAT, Fas/Fas-L, NF-κB pathway activation.

Purpose of the Study:

  • To review the molecular pathogenesis of LGL leukemia.
  • To discuss clinical presentation and associated autoimmune disorders.
  • To explore current and emerging therapeutic strategies.

Main Methods:

  • Review of scientific literature on LGL leukemia.
  • Analysis of molecular pathways involved in LGL leukemia pathogenesis.
  • Evaluation of treatment outcomes and emerging therapies.

Main Results:

  • LGL leukemia pathogenesis involves specific molecular mutations and signaling pathway activation.
  • Recurrent infections due to neutropenia are a major cause of mortality.
  • Current immunosuppressive therapies offer limited long-term efficacy.

Conclusions:

  • Personalized and targeted therapies are crucial for effective LGL leukemia management.
  • Further research into novel therapeutic targets is warranted.
  • Improved treatment strategies are needed to enhance patient outcomes.

Keywords:
STAT3large granular lymphocytic leukemiamolecular pathogenesisnatural killer LGL leukemiatargeted therapies

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.1K
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

20.1K

Related Concept Videos

Classification of Leukocytes01:30

Classification of Leukocytes

Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
1.9K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K